Compounds > monocrotaline

monocrotaline and Muscle Weakness

monocrotaline has been researched along with Muscle Weakness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, M; Himori, K; Lanner, JT; Lee, J; Tatebayashi, D; Westerblad, H; Yamada, T1
de Man, FS; Handoko, ML; Manders, E; Ottenheijm, CA; Stienen, GJ; van Hees, HW; Vonk-Noordegraaf, A; Westerhof, N1

Other Studies

2 other study(ies) available for monocrotaline and Muscle Weakness

ArticleYear
Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.
    PloS one, 2017, Volume: 12, Issue:2

    Topics: Actins; Animals; Antioxidants; Biomimetic Materials; Catalase; Diaphragm; Disease Models, Animal; Glutathione; Hypertension, Pulmonary; Male; Monocrotaline; Muscle Contraction; Muscle Weakness; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Salicylates; Superoxide Dismutase

2017
Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction.
    American journal of physiology. Lung cellular and molecular physiology, 2012, Dec-15, Volume: 303, Issue:12

    Topics: Animals; Calcium; Diaphragm; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Weakness; Myosin Heavy Chains; Rats; Rats, Wistar; Sarcomeres

2012